Gabather

Gabather Debt / Assets

Debt-to-Assets Ratio of Gabather (GABA.ST) as of Oct 28, 2026.

Debt / Assets

0.00

Last updated:

Debt-to-Assets Ratio of Gabather is 2024 0.00 . Debt-to-Assets Ratio of Gabather was 2023 0.00 . It decreases by % lower compared to the previous year.

The Gabather Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2017
0.00 SEK
Jan 1, 2018
0.00 SEK
Jan 1, 2019
0.00 SEK
Jan 1, 2020
0.00 SEK
Jan 1, 2021
0.00 SEK
Jan 1, 2022
0.00 SEK
Jan 1, 2023
0.00 SEK
Jan 1, 2024
0.00 SEK
The Gabather Debt / Assets history
YEARDebt / AssetsYoY
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Gabather Stock analysis

What does Gabather do? Gabather AB engages in the research and development of drug candidates for the treatment of diseases affecting the central nervous system. The firm develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The firm mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease. Gabather is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gabather stock

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Gabather since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Gabather with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Gabather

All Key Metrics — Gabather